{{Rsnum
|rsid=10038113
|Chromosome=5
|position=25902233
|Orientation=plus
|GMAF=0.4885
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.5 | 46.9 | 33.6
| HCB | 41.6 | 39.4 | 19.0
| JPT | 31.9 | 52.2 | 15.9
| YRI | 32.7 | 45.6 | 21.8
| ASW | 21.1 | 73.7 | 5.3
| CHB | 41.6 | 39.4 | 19.0
| CHD | 28.4 | 56.0 | 15.6
| GIH | 19.8 | 47.5 | 32.7
| LWK | 30.9 | 51.8 | 17.3
| MEX | 22.4 | 44.8 | 32.8
| MKK | 25.0 | 53.2 | 21.8
| TSI | 12.7 | 49.0 | 38.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19456320
|Trait=Autism
|Title=A genome-wide association study of autism reveals a common novel risk locus at 5p14.1
|RiskAllele=T
|Pval=0.000003
|OR=1.33
|ORtxt=[1.11-1.43]
|OA=1
}}

{{PharmGKB
|RSID=rs10038113
|Name_s=
|Gene_s=MSNL1
|Feature=
|Evidence=PubMed ID:19404256
|Annotation=This SNP on 5p14.1 was associated with autism spectrum disorder in a combined analysis of four GWAS data sets with a total of more than 10,000 subjects of European ancestry. This SNP is in an intergenic region between CDH10 and CDH9 that contains several highly conserved genomic elements.
|Drugs=
|Drug Classes=
|Diseases=Autism Spectrum Disorder
|Curation Level=Curated
|PharmGKB Accession ID=PA164741100
}}

{{omim
|id=209850
|rsnum=10038113
}}

{{omim
|id=209850
|rsnum=10038113
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10038113
|overall_frequency_n=61
|overall_frequency_d=126
|overall_frequency=0.484127
|n_genomes=44
|n_genomes_annotated=0
|n_haplomes=57
|n_articles=1
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}